NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants (NEOBIFI)
Effects of an Association of the Two Bifidobacteria Probiotics Bifidobacterium Breve B632 and Bifidobacterium Breve BR03 in Intestinal Bacterial Colonization and in the Prevention and/or Reduction of the Incidence of Colics in Infants
Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita
A PHASE4 clinical study on Bifidobacterium Breve and Colic, Infantile, this trial is completed. The trial is conducted by Azienda Ospedaliero Universitaria Maggiore della Carita and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 1 earlier version
-
Aug 2017 — Feb 2018 [monthly]
Recruiting PHASE4
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliero Universitaria Maggiore della Carita
For direct contact, visit the study record on ClinicalTrials.gov .